GEOSPACE TECHNOLOGIES CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GEOSPACE TECHNOLOGIES CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $110.80M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $135.60M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $124.51M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $89.25M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $94.86M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $87.84M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $95.81M | Nov 20, 2020 |
| FY2018 | Sep 30, 2018 | $20.59M | Nov 16, 2018 |
| FY2018 | Jun 30, 2018 | $21.27M | Nov 16, 2018 |
| FY2018 | Mar 31, 2018 | $19.25M | Nov 16, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $110.80M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $135.60M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $124.51M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $89.25M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $75.86M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $34.14M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $45.85M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $53.31M | Nov 22, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Sep 30, 2013 | $68.29M | Nov 22, 2013 |
| FY2013 | Jun 30, 2013 | $78.15M | Nov 22, 2013 |
| FY2013 | Mar 31, 2013 | $76.42M | Nov 22, 2013 |
| FY2013 | Dec 31, 2012 | $77.75M | Nov 22, 2013 |
| FY2012 | Sep 30, 2012 | $36.95M | Dec 12, 2012 |
| FY2012 | Jun 30, 2012 | $55.20M | Dec 12, 2012 |
| FY2012 | Mar 31, 2012 | $56.23M | Dec 12, 2012 |
| FY2012 | Dec 31, 2011 | $43.28M | Dec 12, 2012 |
| FY2012 | Sep 30, 2011 | $32.81M | Dec 12, 2012 |
| FY2012 | Jun 30, 2011 | $46.37M | Dec 12, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $32.90M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $52.57M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $51.69M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $18.04M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $16.29M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $23.43M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $31.43M | Nov 20, 2020 |
| FY2018 | Sep 30, 2018 | $5.26M | Nov 16, 2018 |
| FY2018 | Jun 30, 2018 | $4.68M | Nov 16, 2018 |
| FY2018 | Mar 31, 2018 | $2.00M | Nov 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($9.72M) | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | ($6.58M) | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $12.21M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | ($22.86M) | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | ($14.06M) | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | ($19.24M) | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | ($146.0K) | Nov 20, 2020 |
| FY2018 | Sep 30, 2018 | ($207.0K) | Nov 16, 2018 |
| FY2018 | Jun 30, 2018 | ($4.80M) | Nov 16, 2018 |
| FY2018 | Mar 31, 2018 | ($4.73M) | Nov 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($11.28M) | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $7.12M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $11.33M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | ($23.14M) | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | ($16.87M) | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | ($18.04M) | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $1.03M | Nov 20, 2020 |
| FY2018 | Sep 30, 2018 | ($780.0K) | Nov 16, 2018 |
| FY2018 | Jun 30, 2018 | ($5.14M) | Nov 16, 2018 |
| FY2018 | Mar 31, 2018 | ($5.22M) | Nov 16, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $18.92M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $16.25M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $15.86M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $18.10M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $14.84M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $16.57M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $15.50M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $10.83M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $13.78M | Nov 16, 2018 |
| FY2018 | Sep 30, 2016 | $13.85M | Nov 16, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $29.82M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $26.55M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $25.95M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $23.48M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $21.93M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $23.07M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $23.63M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $19.87M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $20.24M | Nov 16, 2018 |
| FY2018 | Sep 30, 2016 | $21.53M | Nov 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($22.23M) | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | ($9.08M) | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $15.56M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | ($10.04M) | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | ($7.17M) | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $18.12M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $5.63M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | ($10.40M) | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $10.09M | Nov 16, 2018 |
| FY2018 | Sep 30, 2016 | ($1.70M) | Nov 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.97M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $3.86M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $3.96M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $1.13M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $3.19M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $2.92M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $1.94M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $1.72M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $1.18M | Nov 16, 2018 |
| FY2018 | Sep 30, 2016 | $1.87M | Nov 16, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $153.04M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $152.19M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $153.04M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $135.06M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $163.93M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $186.85M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $202.01M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $199.08M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $205.70M | Nov 16, 2018 |
| FY2017 | Jun 30, 2017 | $221.77M | Dec 1, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $27.53M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $17.57M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $20.33M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $13.41M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $21.47M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $25.88M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $23.16M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $22.49M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $10.54M | Nov 16, 2018 |
| FY2017 | Sep 30, 2016 | $10.31M | Dec 1, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $125.51M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $134.62M | Nov 21, 2025 |
| FY2025 | Sep 30, 2023 | $132.72M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $121.65M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $142.46M | Nov 17, 2023 |
| FY2022 | Sep 30, 2020 | $160.97M | Nov 18, 2022 |
| FY2021 | Sep 30, 2019 | $178.85M | Nov 19, 2021 |
| FY2020 | Sep 30, 2018 | $176.59M | Nov 20, 2020 |
| FY2019 | Sep 30, 2017 | $194.80M | Nov 22, 2019 |
| FY2018 | Sep 30, 2016 | $244.47M | Nov 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.26M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $736.0K | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $736.0K | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $736.0K | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $5.07M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $4.34M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $5.01M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $4.34M | Nov 22, 2019 |
| FY2015 | Sep 30, 2014 | $1.84M | Nov 19, 2015 |
| FY2014 | Sep 30, 2013 | $1.84M | Nov 21, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $45.56M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $55.28M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $61.86M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $49.65M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $72.51M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $86.57M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $105.81M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $105.95M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $125.52M | Nov 16, 2018 |
| FY2017 | Sep 30, 2016 | $182.31M | Dec 1, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $26.34M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $6.90M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $18.80M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $16.11M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | $14.07M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $32.69M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $18.93M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | $11.93M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | $15.09M | Nov 16, 2018 |
| FY2017 | Jun 30, 2017 | $17.08M | Dec 1, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $0 | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | $0 | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $0 | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $0 | Nov 17, 2023 |
| FY2014 | Sep 30, 2013 | $931.0K | Nov 21, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | (1) | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | (1) | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | (1) | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | 0 | Nov 20, 2020 |
| FY2018 | Sep 30, 2018 | 0 | Nov 16, 2018 |
| FY2018 | Jun 30, 2018 | 0 | Nov 16, 2018 |
| FY2018 | Mar 31, 2018 | 0 | Nov 16, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | (1) | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | (1) | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | (1) | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | 0 | Nov 20, 2020 |
| FY2018 | Sep 30, 2018 | 0 | Nov 16, 2018 |
| FY2018 | Jun 30, 2018 | 0 | Nov 16, 2018 |
| FY2018 | Mar 31, 2018 | 0 | Nov 16, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 12.82M | Nov 21, 2025 |
| FY2025 | Sep 30, 2024 | 12.71M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | 13.19M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | 13.02M | Nov 17, 2023 |
| FY2022 | Sep 30, 2021 | 12.97M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | 13.67M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | 13.63M | Nov 20, 2020 |
| FY2019 | Sep 30, 2018 | 13.60M | Nov 22, 2019 |
| FY2018 | Sep 30, 2017 | 13.44M | Nov 16, 2018 |
| FY2017 | Sep 30, 2016 | 13.33M | Dec 1, 2017 |